Gerstner Sloan-Kettering - Graduate School of Biomedical Sciences
Return to Formatted Version

GERSTNER SLOAN-KETTERING CORE COURSE TOPICS

FALL SEMESTER

Section 1 - Genome Biology

  • Cancer as a disease
  • Chemistry and structure of mutations
  • Informational content of mutations and screening for mutations
  • Chromosome structure
  • Chromosome replication
  • Drug discovery and development
  • Topoisomerase poisons and nucleoside metabolism effectors as chemotherapeutic agents
  • Linkage analysis
  • Forward and reverse genetics
  • Meiotic recombination
  • Biochemical mechanisms of homologous recombination
  • Double-strand break repair and non-homologous end joining
  • Cytogenetics and cancer
  • Healing DNA/RNA ends and sealing DNA/RNA strands
  • DNA repair
  • Chromosome segregation
  • Chemical biology and chemotherapy of mitotic poisons

Section II - Proteins and Gene Expression

  • Protein structure, folding, and modification
  • Protein structure-function analysis
  • Protein-protein and protein-DNA interactions
  • Errors in protein folding and cancer
  • Mechanics of translation
  • RNA modification
  • Computational and systems biology
  • Mechanics of transcription
  • Methods of experimental perturbation of gene expression and function in culture
  • Gene transfer vectors: experimental and medical applications
  • Clinical manipulation of gene expression
  • Mouse model systems
  • Measurement of gene expression
  • Epigenetics

Section III - Cells and Regulation of the Cell Cycle

  • Cellular membrane structure and function
  • Cytoskeletal architecture
  • Visualization of cells and cellular components
  • Nuclear cytoplasmic export and import
  • Mitochondria and endoplasmic reticulum
  • The secretory pathway and endocytosis
  • The cell cycle
  • The mitotic checkpoint
  • The DNA damage response
  • Apoptosis
  • p53
  • Radiation as a therapeutic agent
  • Current pharmocology of neoplastic agents
  • Exploitation of checkpoints in chemotherapy
  • Phase I design principles: Exploitation of checkpoints in chemotherapy
  • Evolution of preatment protocols

SPRING SEMESTER

Section IV - Signaling and Development

  • Principles of signal transduction and links to oncogenesis
  • Introduction to signaling and cell type specification in development
  • Gastrulation and early morphogenesis in drosophila
  • Gastrulation and early morphogenesis in mammals
  • The Ras and MAP kinase pathways: Normal functions in development
  • The Ras and MAP kinase pathways in disease
  • Wnt--the pathway and its normal functions in development
  • Wnt and cancer
  • TGFb signaling pathway
  • TGFb signaling pathways in development
  • TGFb signaling pathway in disease
  • Hedgehog in development
  • Hedgehog and cancer
  • Notch
  • Crosstalk between signaling pathways
  • Transcription factors in development and cancer
  • Growth control: Akt-Pten-Tor
  • mTor and rapamycin
  • Cell-to-Cell Adhesion and Communication
  • Cell matrix adhesion and signaling
  • Manipulating signal transductions pathways with small molecules
  • Cell migration and invasion
  • Stem cells

Section V - Cancer Immunology

  • Overview of the immune system
  • Innate immunity: NK cells
  • Innate immunity: toll-like receptors
  • Adaptive immunity -- B-cells
  • Adaptive immunity -- T-cells: antigen presentation
  • Adaptive immunity -- T-cells: antigen/MHC recognition and the TCR
  • Adaptive immunity -- T-cells: T cell development
  • Adaptive immunity -- T-cells: regulation of T cell activation
  • Adaptive immunity -- T-cells: T cell effector responses and memory
  • Tumor immunology: Immune system and cancer/immunotherapy of cancer
  • Biostatistics

Section VI - Cancer Biology

  • Basics of clinical trials
  • Anatomic and molecular pathology
  • Molecular imaging
  • Pharmacology of chemotherapy drugs
  • Targeting protein degradation (Hsp 90, etc)
  • Radiation therapy principles
  • Biomarkers
  • Leukemia translocations
  • Sarcoma translocations
  • Molecular classification in lymphoma
  • Kinases in myleproliferative diseases
  • EGFR and Ras and lung cancer
  • Kinases in glioblastoma
  • B-Raf and melanoma
  • Protesome inhibitors and myeloma
  • Hormone-dependent cancers
  • Colon cancer
  • Inherited cancer susceptibility syndromes


Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences
©2009 Memorial Sloan-Kettering Cancer Center